Impact of clinical decision support systems (cdss) on clinical outcomes and healthcare delivery in low- and middle-income countries: protocol for a systematic review and meta-analysis
Jain, Garima, Bodade, Anand, Pati, Sanghamitra
–arXiv.org Artificial Intelligence
Clinical decision support systems (CDSS) are used to improve clinical and service outcomes, yet evidence from low- and middle-income countries (LMICs) is dispersed. This protocol outlines methods to quantify the impact of CDSS on patient and healthcare delivery outcomes in LMICs. We will include comparative quantitative designs (randomized trials, controlled before-after, interrupted time series, comparative cohorts) evaluating CDSS in World Bank-defined LMICs. Standalone qualitative studies are excluded; mixed-methods studies are eligible only if they report comparative quantitative outcomes, for which we will extract the quantitative component. Searches (from inception to 30 September 2024) will cover MEDLINE, Embase, CINAHL, CENTRAL, Web of Science, Global Health, Scopus, IEEE Xplore, LILACS, African Index Medicus, and IndMED, plus grey sources. Screening and extraction will be performed in duplicate. Risk of bias will be assessed with RoB 2 (randomized trials) and ROBINS-I (non-randomized). Random-effects meta-analysis will be performed where outcomes are conceptually or statistically comparable; otherwise, a structured narrative synthesis will be presented. Heterogeneity will be explored using relative and absolute metrics and a priori subgroups or meta-regression (condition area, care level, CDSS type, readiness proxies, study design).
arXiv.org Artificial Intelligence
Nov-3-2025
- Country:
- Africa
- Togo (0.04)
- Lesotho (0.04)
- Mali (0.04)
- Sierra Leone (0.04)
- Burkina Faso (0.04)
- Ethiopia (0.04)
- Sudan (0.04)
- Kenya (0.04)
- South Africa (0.04)
- Saint Helena, Ascension and Tristan da Cunha (0.04)
- Botswana (0.04)
- The Gambia (0.04)
- Nigeria (0.04)
- Central African Republic (0.04)
- Ghana (0.04)
- Eswatini (0.04)
- Namibia (0.04)
- Middle East
- Zimbabwe (0.04)
- Eritrea (0.04)
- Mauritania (0.04)
- Rwanda (0.04)
- Mozambique (0.04)
- Uganda (0.04)
- Gabon (0.04)
- Tanzania (0.04)
- South Sudan (0.04)
- Equatorial Guinea (0.04)
- Madagascar (0.04)
- Malawi (0.04)
- Liberia (0.04)
- São Tomé and Príncipe (0.04)
- Angola (0.04)
- Senegal (0.04)
- Cameroon (0.04)
- Burundi (0.04)
- Guinea-Bissau (0.04)
- Democratic Republic of the Congo (0.04)
- Mauritius (0.04)
- Comoros (0.04)
- Benin (0.04)
- Zambia (0.04)
- Côte d'Ivoire (0.04)
- Asia
- Pakistan (0.04)
- Cambodia (0.04)
- Nepal (0.04)
- Mongolia (0.04)
- Malaysia (0.04)
- Kazakhstan (0.04)
- Uzbekistan (0.04)
- Bangladesh (0.04)
- Bhutan (0.04)
- Azerbaijan (0.04)
- Vietnam (0.04)
- Indonesia (0.04)
- Laos (0.14)
- Middle East
- Iran (0.04)
- Iraq (0.04)
- Jordan (0.04)
- Lebanon (0.04)
- Palestine > Gaza Strip (0.04)
- Republic of Türkiye (0.04)
- Syria (0.04)
- Maldives (0.04)
- Philippines (0.04)
- China (0.04)
- Timor-Leste (0.04)
- Armenia (0.04)
- Myanmar (0.04)
- Kyrgyzstan (0.04)
- Sri Lanka (0.04)
- Turkmenistan (0.04)
- Thailand (0.04)
- Tajikistan (0.04)
- India
- NCT
- Odisha > Bhubaneshwar (0.04)
- Afghanistan (0.04)
- Europe
- Belarus (0.04)
- North Macedonia (0.04)
- Moldova (0.04)
- Kosovo (0.04)
- Ukraine (0.04)
- Serbia (0.04)
- Albania (0.04)
- Bosnia and Herzegovina (0.04)
- Montenegro (0.04)
- North America
- Saint Vincent and the Grenadines (0.04)
- Cuba (0.04)
- Haiti (0.04)
- Saint Lucia (0.04)
- El Salvador (0.04)
- Jamaica (0.04)
- Mexico (0.04)
- Dominica (0.04)
- Guatemala (0.04)
- Nicaragua (0.04)
- Belize (0.04)
- Honduras (0.04)
- Dominican Republic (0.04)
- Costa Rica (0.04)
- Panama (0.04)
- Montserrat (0.04)
- Oceania
- Kiribati (0.04)
- Wallis and Futuna (0.04)
- Fiji (0.04)
- Marshall Islands (0.04)
- Tuvalu (0.04)
- Samoa (0.04)
- Solomon Islands (0.04)
- Tonga (0.04)
- Papua New Guinea (0.04)
- Nauru (0.04)
- Tokelau (0.04)
- Micronesia (0.04)
- Niue (0.04)
- South America
- Africa
- Genre:
- Research Report
- Experimental Study (1.00)
- New Finding (1.00)
- Strength High (1.00)
- Research Report
- Industry:
- Health & Medicine
- Health Care Providers & Services (0.68)
- Health Care Technology (0.69)
- Therapeutic Area
- Cardiology/Vascular Diseases (0.68)
- Endocrinology > Diabetes (0.46)
- Infections and Infectious Diseases (0.68)
- Neurology (0.68)
- Oncology (1.00)
- Health & Medicine
- Technology: